Previous studies have shown that fewer memory and effector CD4+ and CD8+ T cells from peripheral blood of cancer patients can produce IFNγ in contrast to those of healthy individuals, whereas IFNγ-deficient mice, compared with wild-type mice, have demonstrated reduced migration of activated T cells to tumor sites and enhanced tumor progression (17, 18). Here, CD8A is linked to cancer.